Investor · St. Louis, MO

Parker Spann

Open Parker in the network graph →

Filings

10

SEC Form D

Connections

59

co-filers

Capital

—

across filings

Active

Feb 2017

to Nov 2022

Most-connected co-filers (59)

Candace J. Woods · Newark, NJ7 shared Adam G. Yader · Monterey, CA7 shared Jason G. Klarreich · Armonk, NY5 shared Derek Ohly · WALTHAM, MA4 shared Andrew R. Hersant · Grand Cayman, Cayman Islands4 shared Andreas Guldin · Geneva, NY4 shared David Richardson · George Town, Cayman Islands4 shared Joseph Luceri · Long Island City, NY4 shared Scott Perricelli · Philadelphia, PA4 shared Elizabeth Campbell · Long Island City, NY4 shared Steven Gillis · Lexington, MA3 shared Michael H. Kossman · Los Angeles, CA3 shared Carl D. Forster · Los Angeles, CA3 shared Bret R. Magpiong · Los Angeles, CA3 shared Kevin S. Woolf · Winter Haven, FL3 shared Marc S. Primiani · Los Angeles, CA3 shared Kenneth J. Anderson · Los Angeles, CA3 shared Jeffery T. Donalson · Winter Haven, FL3 shared Neil R. Hokanson · LOS ANGELES, CA3 shared Stephen Hill · Seattle, WA3 shared J. C. Snellings · Atlanta, GA3 shared Frederick D. Clemente · Atlanta, GA3 shared Peng D. Lee · Atlanta, GA3 shared Robert J. Francais · Los Angeles, CA3 shared

Recent filings (10)

Spann Access Fund I, LPMar 2025 · 1 co-filer Spann Access Fund I, LPMar 2025 · 1 co-filer Faraday Pharmaceuticals, Inc.Nov 2022 · 23 co-filers$102.8M Faraday Pharmaceuticals, Inc.Sep 2019 · 13 co-filers$30.1M Faraday Pharmaceuticals, Inc.Mar 2019 · 17 co-filers$10.0M Protocol Fund LPFeb 2019 · 2 co-filers Protocol Fund LPJan 2018 · 2 co-filers Aspiriant Holdings S5, LLCApr 2017 · 36 co-filers$6.9M Aspiriant Holdings S5, LLCFeb 2017 · 36 co-filers$100 Faraday Pharmaceuticals, Inc.Feb 2017 · 19 co-filers$32.8M ASPIRIANT, LLCFeb 2017 · 35 co-filers$6.9M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Parker in the interactive graph →